Shell Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Shell Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,579	Closed	-$163K	–	1257
2019 Q1	$163K	Hold	6,579	–	–	﹤0.01%	1131
2018 Q4	$118K	Sell	6,579 -500	-7%	-$10.2K	﹤0.01%	1083
2018 Q3	$208K	Hold	7,079	–	–	﹤0.01%	1097
2018 Q2	$322K	Sell	7,079 -401	-5%	-$19.5K	0.01%	1016
2018 Q1	$395K	Hold	7,480	–	–	0.01%	969
2017 Q4	$509K	Hold	7,480	–	–	0.01%	904
2017 Q3	$616K	Sell	7,480 -200	-3%	-$15.9K	0.01%	780
2017 Q2	$719K	Hold	7,680	–	–	0.02%	775
2017 Q1	$489K	Buy	+7,680	New	+$467K	0.01%	911

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Shell Asset Management's CLVS Position: Q2 2019 in Review

Shell Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 6,579 shares — an estimated $163K sold.

Shell Asset Management first reported a position in CLVS in Q1 2017 and held it in 9 quarters. The position peaked at $719K in Q2 2017. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

Shell Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
Shell Asset Management sold 6,579 Clovis Oncology, Inc. shares in Q2 2019, an estimated $163K.
Shell Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 9 quarters.
Shell Asset Management's Clovis Oncology, Inc. position peaked at $719K in Q2 2017.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Shell Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.